El contenido de este sitio está destinado solo a profesionales de la salud
This module was developed to support the clinical practice of physicians prescribing biosimilar medicines to cancer patients. The content is designed to promote a clear understanding of biosimilar medicines with a focus on improving patient education through good communication.
This project was made possible through a collaboration between European Cancer Patient Coalition (ECPC), King’s College London and ecancer.
Published July 2019.
This module has been developed for clinicians prescribing biosimilars to patients.
By the end of the module you will:
This module requires the learner to have a good, stable internet connection and can run on Internet Explorer 7 and above, Mozilla Firefox, Google Chrome and Opera on either Windows or MacOS. Flash Add-on is also required to run this module.
If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.
If you are experiencing technical difficulties, please contact education@ecancer.org and we will get back to you as soon as possible.
ecancer and everyone involved in the development of this module has no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from Pfizer.
Pfizer has had no input in the creation of the e-learning materials including the process of selecting speakers.
For more information please contact education@ecancer.org.
Production of this module was funded by an unrestricted grant from Pfizer.
